1. Home
  2. IRT vs PCVX Comparison

IRT vs PCVX Comparison

Compare IRT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRT
  • PCVX
  • Stock Information
  • Founded
  • IRT 2009
  • PCVX 2013
  • Country
  • IRT United States
  • PCVX United States
  • Employees
  • IRT N/A
  • PCVX N/A
  • Industry
  • IRT Real Estate Investment Trusts
  • PCVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRT Real Estate
  • PCVX Health Care
  • Exchange
  • IRT Nasdaq
  • PCVX Nasdaq
  • Market Cap
  • IRT 4.3B
  • PCVX 4.2B
  • IPO Year
  • IRT 2013
  • PCVX 2020
  • Fundamental
  • Price
  • IRT $17.73
  • PCVX $32.87
  • Analyst Decision
  • IRT Buy
  • PCVX Strong Buy
  • Analyst Count
  • IRT 10
  • PCVX 10
  • Target Price
  • IRT $22.70
  • PCVX $136.50
  • AVG Volume (30 Days)
  • IRT 1.9M
  • PCVX 1.6M
  • Earning Date
  • IRT 07-30-2025
  • PCVX 08-05-2025
  • Dividend Yield
  • IRT 3.84%
  • PCVX N/A
  • EPS Growth
  • IRT N/A
  • PCVX N/A
  • EPS
  • IRT 0.13
  • PCVX N/A
  • Revenue
  • IRT $641,330,000.00
  • PCVX N/A
  • Revenue This Year
  • IRT $5.23
  • PCVX N/A
  • Revenue Next Year
  • IRT $6.20
  • PCVX N/A
  • P/E Ratio
  • IRT $136.48
  • PCVX N/A
  • Revenue Growth
  • IRT N/A
  • PCVX N/A
  • 52 Week Low
  • IRT $17.10
  • PCVX $27.66
  • 52 Week High
  • IRT $22.26
  • PCVX $121.06
  • Technical
  • Relative Strength Index (RSI)
  • IRT 35.61
  • PCVX 43.55
  • Support Level
  • IRT $17.74
  • PCVX $33.24
  • Resistance Level
  • IRT $18.02
  • PCVX $34.94
  • Average True Range (ATR)
  • IRT 0.37
  • PCVX 1.55
  • MACD
  • IRT -0.04
  • PCVX -0.07
  • Stochastic Oscillator
  • IRT 10.22
  • PCVX 6.28

About IRT Independence Realty Trust Inc.

Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: